Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Potential Role of Inflammation in SARS-CoV-2 Disease Pathology: A multi-omic study in Type II pneumocytes of A/J mice exposed to Lipopolysaccharide

ABSTRACT: Multi-omic analyses of A/J Type II pneumocytes exposed to lipopolysaccharide were performed to ascertain the similarity of the inflammatory response under these conditions to the inflammatory response seen in SARS-CoV-2 infections.

ORGANISM(S): Mus musculus

PROVIDER: GSE211061 | GEO | 2022/08/15

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

A multi-omics study of epigenetic changes in type II alveolar cells in A/J mice exposed to lipopolysaccharide and environmental tobacco smoke

Project description:A/J mice were exposed to environmental tobacco smoke, lipopolysaccharide, or clean air over the course of several weeks. Following exposure, subjects were sacrificed and their type II pneumocytes were isolated for multi-omic analyses.

2025-05-07 | PXD054404 | Pride

Multi-omics analysis of the epigenetic effects of lipopolysaccharide-induced inflammation in Type II Pneumocytes

Project description:Chronic inflammation plays a central role in the pathogenesis of many lung diseases including asthma, SARS-COVID19, obstructive pulmonary disease (COPD), and lung cancer. Lipopolysaccharide (LPS) is an inflammatory agent produced by most Gram-negative bacteria and found in cigarette smoke. In a mouse model of inflammation, inhalation exposure to LPS induced COPD and increased the size and the multiplicity of lung tumors induced by tobacco-specific nitrosamines. In the present work, we employed a comprehensive multi-omics approach that monitored changes in DNA methylation/hydroxymethylation, gene expression, and global protein abundances in Type II pneumocytes of A/J mice following sub-chronic exposure to LPS.

2025-06-04 | GSE275769 | GEO

Potential Role of Inflammation in SARS-CoV-2 Disease Pathology: A multi-omic study in Type II pneumocytes of A/J mice exposed to Lipopolysaccharide

Project description:Potential Role of Inflammation in SARS-CoV-2 Disease Pathology: A multi-omic study in Type II pneumocytes of A/J mice exposed to Lipopolysaccharide

| PRJNA868752 | ENA

Comparison of KRas;Atg5fl/+ and KRas;Atg5fl/fl pneumocytes

Project description:Primary pneumocytes from KRas;Atg5fl/+ and KRas;Atg5fl/fl littermates were cultured for 48 hours and infected with AdCre-GFP to induce expression of the KrasG12D oncogene and concomitant Atg5 deletion. The transcriptional profile of those cells was determined by mRNA sequencing and uncovered differential expression in cellular movement, inflammatory response and oxidative stress response. Comparison of transcriptomes from KRas;Atg5fl/+ and KRas;Atg5fl/fl pneumocytes

2014-01-07 | E-GEOD-48387 | biostudies-arrayexpress

Multi-omics analysis of the epigenetic effects of lipopolysaccharide-induced inflammation in Type II Pneumocytes

Project description:Multi-omics analysis of the epigenetic effects of lipopolysaccharide-induced inflammation in Type II Pneumocytes

| PRJNA1152971 | ENA

Comparison of KRas;Atg5fl/+ and KRas;Atg5fl/fl pneumocytes

2014-01-07 | GSE48387 | GEO

RNAseq of CD31-/CD45- pneumocytes after 4 weeks of KRasG12V activation by tamoxifen

Project description:We report the RNAseq data obtained from 50.000-100.000 CD31-/CD45- pneumocytes isolated by FACS from mice harboring a normal dose or one extra copy of the Sirt1 gene, and a tamoxifen-inducible oncogenic KI alelle of KRasG12V after 4 weeks of tamoxifen treatment. Pneumocytes with the activated form of the inducible KRasG12V oncogene sere selected making use of the reporter gene LacZ (located next to the oncogene in the same polycistronic mRNA), by loading CD31-/CD45- pneumocytes with the LacZ-activated fuorogenic molecule FDG prior to FACS sorting.

2018-06-25 | GSE115179 | GEO

Gene expression data from type II pneumocytes from adult mice with and without Trf2

Project description:Gas exchange in the mammalian lung occurs in the alveolar sacs lined by epithelial cells that form a barrier allowing effective oxygen diffusion. Telomere syndromes have their most common manifestation in degenerative disease of the alveoli, both pulmonary fibrosis and emphysema. We tested the role of telomere dysfunction by inducing deletion of the telomere binding protein Trf2 in type 2 alveolar epithelial cells (AEC2s) that both express the gene encoding surfactant protein C and constitute the regenerative compartment of the alveolar epithelium. Acquired telomere dysfunction in these cells preferentially induced cellular senescence, and mouse lungs were marked by an inflammatory response even though the telomere dysfunction was restricted to the epithelium. Senescent AECs had altered gene expression that differentially fell in inflammatory cell signaling pathways. Bleomycin challenge was uniformly fatal, and Trf2-depleted cells failed to generate clonal alveolar colonies in vitro. The telomere dysfunction response in AEC2s was in part p53-dependent, and we found evidence of a p53-mediated paracrine survival signal to the mesenchyme. These data indicate that telomere dysfunction in the alveolar epithelium limits its regenerative capacity and is sufficient to induce inflammation. It may thus be a primary driving event in telomere-mediated lung disease. Efforts to restore epithelial regenerative capacity may be an effective approach in a subset of fibrosis and emphysema patients. We studied the gene expression changes in adult type II pneumocytes 7 days after deleting Trf2. Mice carried floxed allele of Trf2 and mTmG reporter allele. Type II pneumocytes were collected by FACs sorting GFP+ cells from lungs 7 days after administering tamoxifen. 6 total samples were analysed. Three were from control samples that were heterozygous for Trf2 and three samples had Trf2 deleted.

2015-04-20 | E-GEOD-56892 | biostudies-arrayexpress

RNAseq of CD31-/CD45- pneumocytes after 4 weeks of KRasG12V activation by tamoxifen and 2 weeks of chase

Project description:We report the RNAseq data obtained from 50.000-100.000 CD31-/CD45- pneumocytes isolated by FACS from mice harboring a normal dose or one extra copy of the Sirt1 gene, and a tamoxifen-inducible oncogenic KI alelle of KRasG12V after 4 weeks of tamoxifen treatment plus 2 weeks without tamoxifen. Pneumocytes with the activated form of the inducible KRasG12V oncogene sere selected making use of the fluorescent reporter gene Katushka (located at an independent locus), by detecting Katushka fluorescence.

2018-06-25 | GSE115186 | GEO

Gene expression data from type II pneumocytes from adult mice with and without Trf2

2015-04-20 | GSE56892 | GEO